Logo Volv Global
Contact
Creating new healthcare paradigms

Where technology meets Human

Volv Global personalises healthcare by generating insight into patients and diseases, powered by data-driven AI and machine learning.

Our proprietary machine learning methodologies serve pharmaceutical companies, reducing costs across the healthcare ecosystem and improving outcomes for people living with disease.

Black and white portrait of a smiling young woman with long hair Black and white portrait of a smiling young woman with long hair

Personalising the
patient journey

Volv Global tailors diagnosis, treatment and care pathways to each patient's own data, replacing generic assumptions with the precision and personalisation their specific case actually needs.

Targeting patient populations

Volv Global's methodology characterises and segments patient populations, giving healthcare organisations and patients clearer pathways, and pharmaceutical teams more efficient development and commercialisation.

Expanding medical knowledge

Volv Global generates new understanding of patient biomarkers, phenotypes, clinical features and endpoints, helping clinicians see how a disease presents.

Improving health-
care efficiency

Late and incorrect diagnosis carries an avoidable cost across the system, from unnecessary testing to delayed care. Volv Global's methodology helps payers and providers lower that burden and improve outcomes.

A smiling woman wearing a black hijab, standing with arms crossed against a plain background.

Insight that supports smarter decisions

Adding value through population-scale insight

Volv Global uses AI and real-world data to generate knowledge about difficult-to-diagnose diseases.

Clients use these insights to strengthen clinical development strategy, deepen disease understanding, and find opportunities to develop diagnostic tools faster.

The same insights support repositioning existing drugs to extend their R&D viability, helping clients reach new markets and work smarter.

Every individual matters

Volv Global's methodology powers outcomes across stakeholders

Impact across the product lifecycle​

Clinical
Development

De-risk clinical strategy, strengthening trial planning around a clearer patient picture.

Value and
Access, HEOR

Generate real-world evidence, supporting pricing and reimbursement decisions.

Medical
Affairs

Expand medical understanding with new real-world data insight into disease progression and outcomes.

Commercial
Excellence

Support a strong launch and extend the product lifecycle by finding more patients sooner.

Innovating for patients that routine care overlooks

AI-powered solutions for rare and difficult-to-diagnose disease

Volv Global combines AI with real-world data to deliver solutions for people with rare and difficult-to-diagnose diseases. Its methodology surfaces patients whose data is consistent with detected patterns, generates real-world evidence for clinical trials and regulatory submissions, optimises the patient journey with data-driven insight, and reduces time and cost in drug development and market access.

Pharmaceutical innovators, healthcare providers and policymakers working with Volv Global gain the tools to make faster, better-supported decisions across the healthcare ecosystem.

Volv Global,
in numbers

billion medical
events
0
billion person-years
of health data
0
published first
AI/ML papers
0
Black and white portrait of an older man wearing a cap, looking at the camera

Introducing our methodology

One methodology, built for any difficult-to-diagnose disease

Volv Global’s proprietary methodology finds the patients a health system cannot yet see, flags patients for HCP-led review before conventional symptoms may appear, predicts what happens next, and recognises who is eligible for treatment now. It can be adapted to any difficult-to-diagnose disease, helping clinicians reach people sooner.

Discover our methodology

Understanding how each disease presents, patient by patient

Our solutions

inTrigue
finds
patients

Grow the pool of real-world evidence on a disease, giving healthcare teams a clearer view of who is affected.

inAdvance
detects
disease earlier

Surface subtle patterns among biomarkers, recognising patients on a trajectory towards a condition sometimes years before conventional signs appear.

inFlow
predicts what
happens next

Draw on real-world evidence to model disease progression for patients already diagnosed, anticipating response and outcomes clinicians can plan around.

inCare
finds eligible
patients

Find patients who are already diagnosed but not yet on treatment, closing the gap between diagnosis and care for healthcare organisations and patients alike.

New knowledge, at speed

Portrait of a young girl looking at the camera, black and white photo

The human story

Improving lives with better technology and treatments

Volv Global gives pharmaceutical innovators insight into difficult-to-diagnose diseases, so they can develop effective technology and treatments.

For the patient, this can mean an earlier diagnosis, a life-changing drug, or the chance to connect with a wider community for education and support while living with a rare disease.

Patient resources

Stay informed

Insights & Events

Go​ deeper

Case studies​

See more
Logo Volv Global

Your challenge

Our technology

Our solutions

Knowledge Hub

Meet Volv Global

Proprietary Machine Learning Methodology